• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像用于肝细胞癌监测:一项系统评价和荟萃分析。

Magnetic Resonance Imaging for Surveillance of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

作者信息

Kim Dong Hwan, Choi Sang Hyun, Shim Ju Hyun, Kim So Yeon, Lee Seung Soo, Byun Jae Ho, Kim Kyung Won, Choi Joon-Il

机构信息

Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.

Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Korea.

出版信息

Diagnostics (Basel). 2021 Sep 12;11(9):1665. doi: 10.3390/diagnostics11091665.

DOI:10.3390/diagnostics11091665
PMID:34574006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8469328/
Abstract

Our meta-analysis aimed to evaluate the diagnostic performance of surveillance magnetic resonance imaging (sMRI) for detecting hepatocellular carcinoma (HCC), and to compare the diagnostic performance of sMRI between different protocols. Original articles about the diagnostic accuracy of sMRI for detecting HCC were found in major databases. The meta-analytic pooled sensitivity and specificity of sMRI for detecting HCC were determined using a bivariate random effects model. The pooled sensitivity and specificity of full MRI and abbreviated MRI protocols were compared using bivariate meta-regression. In the total seven included studies (1830 patients), the pooled sensitivity of sMRI for any-stage HCC and very early-stage HCC were 85% (95% confidence interval, 79-90%; = 0%) and 77% (66-85%; = 32%), respectively. The pooled specificity for any-stage HCC and very early-stage HCC were 94% (90-97%; = 94%) and 94% (88-97%; = 96%), respectively. The pooled sensitivity and specificity of abbreviated MRI protocols were 87% (80-94%) and 94% (90-98%), values that were comparable with those of full MRI protocols (84% [76-91%] and 94% [89-99%]; = 0.83). In conclusion, sMRI had good sensitivity for detecting HCC, particularly very early-stage HCC. Abbreviated MRI protocols for HCC surveillance had comparable diagnostic performance to full MRI protocols.

摘要

我们的荟萃分析旨在评估监测磁共振成像(sMRI)检测肝细胞癌(HCC)的诊断性能,并比较不同方案之间sMRI的诊断性能。在主要数据库中查找了关于sMRI检测HCC诊断准确性的原始文章。使用双变量随机效应模型确定sMRI检测HCC的荟萃分析合并敏感性和特异性。使用双变量元回归比较了全MRI和简化MRI方案的合并敏感性和特异性。在总共纳入的7项研究(1830例患者)中,sMRI对任何阶段HCC和极早期HCC的合并敏感性分别为85%(95%置信区间,79-90%;I² = 0%)和77%(66-85%;I² = 32%)。对任何阶段HCC和极早期HCC的合并特异性分别为94%(90-97%;I² = 94%)和94%(88-97%;I² = 96%)。简化MRI方案的合并敏感性和特异性分别为87%(80-94%)和94%(90-98%),这些值与全MRI方案的合并敏感性和特异性(84% [76-91%]和94% [89-99%];P = 0.83)相当。总之,sMRI检测HCC具有良好的敏感性,尤其是极早期HCC。用于HCC监测的简化MRI方案与全MRI方案具有相当的诊断性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c346/8469328/adab7c2ab354/diagnostics-11-01665-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c346/8469328/adab7c2ab354/diagnostics-11-01665-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c346/8469328/adab7c2ab354/diagnostics-11-01665-g002.jpg

相似文献

1
Magnetic Resonance Imaging for Surveillance of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.磁共振成像用于肝细胞癌监测:一项系统评价和荟萃分析。
Diagnostics (Basel). 2021 Sep 12;11(9):1665. doi: 10.3390/diagnostics11091665.
2
Meta-Analysis of the Accuracy of Abbreviated Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: Non-Contrast versus Hepatobiliary Phase-Abbreviated Magnetic Resonance Imaging.用于肝细胞癌监测的简化磁共振成像准确性的Meta分析:非增强与肝胆期简化磁共振成像
Cancers (Basel). 2021 Jun 14;13(12):2975. doi: 10.3390/cancers13122975.
3
Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis.用于肝细胞癌筛查的简化 MRI:系统评价和荟萃分析。
J Hepatol. 2021 Jul;75(1):108-119. doi: 10.1016/j.jhep.2021.01.041. Epub 2021 Feb 3.
4
Abbreviated MRI for Hepatocellular Carcinoma Surveillance - A Systematic Review and Meta-analysis.用于肝细胞癌监测的简化 MRI:系统评价和荟萃分析。
Acad Radiol. 2024 Aug;31(8):3142-3156. doi: 10.1016/j.acra.2024.01.028. Epub 2024 Feb 27.
5
Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas.对比在初诊肝细胞癌患者中应用钆塞酸二钠行非对比 MRI 和简化 MRI 的诊断性能:一项肝细胞癌监测的模拟研究。
Eur Radiol. 2020 Aug;30(8):4150-4163. doi: 10.1007/s00330-020-06754-4. Epub 2020 Mar 12.
6
Diagnostic Performance of KLCA-NCC 2018 Criteria for Hepatocellular Carcinoma Using Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis.KLCA-NCC 2018标准利用磁共振成像诊断肝细胞癌的效能:一项系统评价和Meta分析
Diagnostics (Basel). 2021 Sep 25;11(10):1763. doi: 10.3390/diagnostics11101763.
7
Diagnostic performance of MRI for HCC according to contrast agent type: a systematic review and meta-analysis.根据造影剂类型评估 MRI 对 HCC 的诊断性能:系统评价和荟萃分析。
Hepatol Int. 2020 Dec;14(6):1009-1022. doi: 10.1007/s12072-020-10100-7. Epub 2020 Nov 4.
8
LI-RADS Major Features on MRI for Diagnosing Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.LI-RADS 磁共振成像诊断肝细胞癌的主要特征:系统评价和荟萃分析。
J Magn Reson Imaging. 2021 Aug;54(2):518-525. doi: 10.1002/jmri.27570. Epub 2021 Feb 27.
9
Diagnostic performance of Liver Imaging Reporting and Data System treatment response algorithm: a systematic review and meta-analysis.肝脏影像报告和数据系统治疗反应算法的诊断性能:系统评价和荟萃分析。
Eur Radiol. 2021 Jul;31(7):4785-4793. doi: 10.1007/s00330-020-07464-7. Epub 2021 Jan 6.
10

引用本文的文献

1
Detection of Early-Stage Hepatocellular Carcinoma Using Abbreviated Magnetic Resonance Imaging.使用简化磁共振成像检测早期肝细胞癌
Gastroenterol Hepatol (N Y). 2022 Dec;18(12):721-723.
2
Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art Review.肝细胞癌的影像学诊断:最新进展综述
Diagnostics (Basel). 2023 Feb 8;13(4):625. doi: 10.3390/diagnostics13040625.
3
Strategies and Techniques for Liver Magnetic Resonance Imaging: New and Pending Applications for Routine Clinical Practice.肝脏磁共振成像的策略与技术:常规临床实践中的新应用及待应用情况

本文引用的文献

1
Gadoxetate-enhanced Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Preliminary Experience.钆塞酸增强简化MRI用于肝细胞癌监测:初步经验
Radiol Imaging Cancer. 2019 Nov 29;1(2):e190010. doi: 10.1148/rycan.2019190010. eCollection 2019 Nov.
2
HCC screening: assessment of an abbreviated non-contrast MRI protocol.肝细胞癌筛查:一种简化的非增强磁共振成像方案的评估
Eur Radiol Exp. 2019 Dec 18;3(1):49. doi: 10.1186/s41747-019-0126-1.
3
Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: Comparison with ultrasound.
Korean J Radiol. 2023 Mar;24(3):180-189. doi: 10.3348/kjr.2022.0838. Epub 2023 Feb 6.
4
Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma.多中心验证用于检测早期肝细胞癌的简化 MRI
Radiology. 2023 Apr;307(2):e220917. doi: 10.1148/radiol.220917. Epub 2023 Jan 24.
5
Risk stratification and early detection biomarkers for precision HCC screening.肝癌精准筛查的风险分层和早期检测生物标志物。
Hepatology. 2023 Jul 1;78(1):319-362. doi: 10.1002/hep.32779. Epub 2022 Oct 11.
6
Current Landscape and Future Perspectives of Abbreviated MRI for Hepatocellular Carcinoma Surveillance.用于肝细胞癌监测的简化 MRI 的现状和未来展望。
Korean J Radiol. 2022 Jun;23(6):598-614. doi: 10.3348/kjr.2021.0896. Epub 2022 Apr 13.
非增强磁共振成像作为肝细胞癌的监测工具:与超声的比较。
J Hepatol. 2020 Apr;72(4):718-724. doi: 10.1016/j.jhep.2019.12.001. Epub 2019 Dec 10.
4
Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients.年度对比增强磁共振成像在肝硬化患者肝癌监测中具有高度有效性。
Eur J Gastroenterol Hepatol. 2020 Apr;32(4):517-523. doi: 10.1097/MEG.0000000000001528.
5
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update.肝细胞癌临床实践指南:日本肝脏学会2017年(第4版日本肝脏学会肝细胞癌指南)2019年更新版
Hepatol Res. 2019 Oct;49(10):1109-1113. doi: 10.1111/hepr.13411. Epub 2019 Sep 6.
6
2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.2018 韩国肝癌协会-韩国国家癌症中心肝细胞癌管理实践指南。
Gut Liver. 2019 May 15;13(3):227-299. doi: 10.5009/gnl19024.
7
Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.肝细胞癌监测:当前最佳实践和未来方向。
Gastroenterology. 2019 Jul;157(1):54-64. doi: 10.1053/j.gastro.2019.02.049. Epub 2019 Apr 12.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南:肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
10
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.肝细胞癌的诊断、分期及管理:美国肝病研究协会2018年实践指南
Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.